glp-1 weight loss journey Loss: My 14-Week, 32-Pound Before & After Journey! Before and after GLP-1: what

It comes down to what fits your life

Not perfect

Grabauskas, G

The DPP-4 inhibitor CV safety outcome trials have unequivocally demonstrated that DPP-4 inhibition is not associated with any increased risk of major adverse CV events (MACE), with the four trials so far published (124127) having hazard ratios (HR) for the primary outcome of between 0.96 and 1.02 (Table 2)

Most common side-effects The most common side effects are gastrointestinal and often improve over time: Nausea (most common) Vomiting Constipation or diarrhea GERD / acid reflux Bloating and early satiety Fatigue Less common but more serious risks include: Gallbladder disease Pancreatitis (rare) 10